Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Eschbach, J. W., Egrie, J. C., Downing, M. R., Browne, J. K., Adamson, J. W.: Correction of the anaemia of end stage renal disease with recombinant human erythropoietin: Results of a combined phase 1 and 11 clinical trial.N. Engl. J. Med., 310, 73 (1987).
2. Winearis, C. G., Oliver, D. O., Pipparel, M. J., Reid, C., Downing, M. R., Cotes, P. M.: Effects of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.Lancet, 11, 1175 (1986).
3. Eschbach, J. W., Adamson, J. W.: Recombinant human erythropoietin: Implication for nephrology,Am. J. Kidney Dis., 11, 203 (1988).
4. Delano, B. G.: Improvements in quality of life following treatment with rHuEPO in anaemic haemodialysis patients,Am. J. Kidney Dis., 14, S14 (1989).
5. Nissensson, A. R.: Recombinant human erythropoietin: Impact on brain and congestive function, exercise tolerance, sexual potency and quality of life.Semin. Nephrol., 9, S25 (1989).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献